Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BlueWhale Bio
AddedFeb 15, 2024
UpdatedJun 18, 2026
BlueWhale Bio

BlueWhale Bio

Philadelphia-based BlueWhale Bio accelerates cell-based therapies through innovative manufacturing.

HQ
Philadelphia, PA, US
Overview
Compare
Fundraising
Employees
Website

BlueWhale Bio, founded in Philadelphia as a spinout from the University of Pennsylvania, is dedicated to accelerating the growth and adoption of cell-based therapies. The company's core mission is to address the critical supply-demand imbalance in cell therapy products by innovating manufacturing processes. BlueWhale Bio develops a portfolio of groundbreaking products aimed at delivering the full benefits of cell therapy to more patients, faster and at lower costs.

Notable individuals affiliated with BlueWhale Bio include its founders from the University of Pennsylvania, who bring significant expertise in cell-based therapies. The company has garnered attention for its innovative approach to manufacturing, which has the potential to revolutionize the cell therapy market. By making these therapies more accessible and affordable, BlueWhale Bio is poised to have a substantial impact on the medical field, particularly in treating complex diseases.

BlueWhale Bio - Similar Companies

Be Biopharma logo

Be Biopharma

Cell BioEngines logo

Cell BioEngines

cellbioengines.com

Interius BioTherapeutics logo

Interius BioTherapeutics

interiusbio.com

Beilai Bio logo

Beilai Bio

baylxinc.com

BioHybrid Solutions logo

BioHybrid Solutions

Celularity logo

Celularity

celularity.com

Platelet BioGenesis logo

Platelet BioGenesis

Wheeler Bio logo

Wheeler Bio

wheelerbio.com

Surf Bio logo

Surf Bio

surf.bio

Kincell Bio logo

Kincell Bio

kincellbio.com

ElevateBio logo

ElevateBio

Cellibre logo

Cellibre

cellibre.com

Xcell Biosciences logo

Xcell Biosciences

xcellbio.com

Cellevolve Bio logo

Cellevolve Bio

cellevolve.com

Spheringenics logo

Spheringenics

BlueWhale Bio - Quick Facts

Who are BlueWhale Bio's competitors?

Companies similar to BlueWhale Bio include Be Biopharma, Cell BioEngines, Interius BioTherapeutics and Beilai Bio.

Where is BlueWhale Bio's headquarters located?

BlueWhale Bio's headquarters is located in Philadelphia, PA, US.

When was BlueWhale Bio's last funding round?

BlueWhale Bio's most recent funding round was for $18M (USD) in September 2023.

How much has BlueWhale Bio raised to-date?

As of Sep 7, 2023, BlueWhale Bio has raised a total of $18M (USD).

How many employees does BlueWhale Bio have?

BlueWhale Bio has 30 employees as of Feb 4, 2024.

BlueWhale Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Model
  • Platform
Customer
  • Consumers
Main Product
  • Cell Therapies
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 6 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified